RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mahavir Chougule to Powders

This is a "connection" page, showing publications Mahavir Chougule has written about Powders.
Connection Strength

1.196
  1. Chougule M, Padhi B, Misra A. Development of spray dried liposomal dry powder inhaler of Dapsone. AAPS PharmSciTech. 2008; 9(1):47-53.
    View in: PubMed
    Score: 0.313
  2. Chougule MB, Padhi BK, Jinturkar KA, Misra A. Development of dry powder inhalers. Recent Pat Drug Deliv Formul. 2007; 1(1):11-21.
    View in: PubMed
    Score: 0.291
  3. Shahin HI, Vinjamuri BP, Mahmoud AA, Shamma RN, Mansour SM, Ammar HO, Ghorab MM, Chougule MB, Chablani L. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension. J Control Release. 2019 05 28; 302:126-139.
    View in: PubMed
    Score: 0.170
  4. Misra A, Jinturkar K, Patel D, Lalani J, Chougule M. Recent advances in liposomal dry powder formulations: preparation and evaluation. Expert Opin Drug Deliv. 2009 Jan; 6(1):71-89.
    View in: PubMed
    Score: 0.084
  5. Patel G, Chougule M, Singh M, Misra A. Chapter 9 - Nanoliposomal dry powder formulations. Methods Enzymol. 2009; 464:167-91.
    View in: PubMed
    Score: 0.084
  6. Chougule M, Padhi B, Misra A. Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics. Int J Nanomedicine. 2007; 2(4):675-88.
    View in: PubMed
    Score: 0.073
  7. Chougule MB, Padhi BK, Misra A. Nano-liposomal dry powder inhaler of Amiloride Hydrochloride. J Nanosci Nanotechnol. 2006 Sep-Oct; 6(9-10):3001-9.
    View in: PubMed
    Score: 0.071
  8. Padhi BK, Chougule MB, Misra A. Optimization of formulation components and characterization of large respirable powders containing high therapeutic payload. Pharm Dev Technol. 2006; 11(4):465-75.
    View in: PubMed
    Score: 0.068
  9. Haware RV, Vinjamuri BP, Gavireddi M, Dave VS, Gupta D, Chougule MB, Stagner WC. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions. Pharm Dev Technol. 2019 Jun; 24(5):550-559.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support